WLDN vs GERN Comparison

Willdan Group Inc is a technical services company focused on energy and infrastructure solutions. The company's solutions include energy planning and analytics, consulting, software, public finance, engineering, and program implementation. It operates through two segments: i) Energy segment: It provides specialized, comprehensive energy solutions to businesses, utilities, state agencies, municipalities, and non-profit organizations. ii) Engineering & Consulting: It provides civil engineering and construction management, building and safety services, city engineering and planning support, civil design, geotechnical services, and material testing. The majority of revenue is derived from the Energy segment. Geographically, all of the company's revenue is generated from the United States.

Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.